Summary
Updated Aug 31, 2026
Frank L. Jaksch Jr. is Director of Niagen Bioscience, Inc. (NAGE). 2 SEC Form 4 filings on record going back to 2024, most recently on 26 June 2026. Most recent open-market trade: sold $230K of NAGE on 13 December 2024. Lifetime open-market sales: $230K.
Recent Transactions
2Every recent SEC Form 4 transaction Frank L. Jaksch Jr. has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Frank L. Jaksch Jr. go back to 2024: 2 primary Form 4 filings, an average of 0.7 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Frank L. Jaksch Jr. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ozan Pamir - $46K of NAGE open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Frank L. Jaksch Jr.?
Frank L. Jaksch Jr. is a corporate insider, tracked as Director of Niagen Bioscience, Inc. (NAGE). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Frank L. Jaksch Jr. submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Frank L. Jaksch Jr. been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($230K) across all tracked filings.
Where can I see all of Frank L. Jaksch Jr.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Frank L. Jaksch Jr. and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial